Document Detail


Efficacy of hybrid therapy in the form of right atrial ablation and adjunctive therapy in refractory atrial fibrillation in symptomatic patients.
MedLine Citation:
PMID:  20720486     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Symptomatic atrial fibrillation is often treated with antiarrhythmic drugs. Responsiveness is poor and adverse effects common. Nonpharmacologic treatments consisting of the Maze procedure and catheter-based pulmonary vein isolation are highly successful but invasive with complications. Right atrial ablation is relatively simple in comparison. Success ranges between 20% and 80%. Some studies have shown improved response when combined with antiarrhythmic drugs (AADs). We performed a review of available literature to determine the efficacy of hybrid therapy in the form of right atrial ablation, AAD with cardioversion, and pacing in reducing atrial fibrillation burden. All human studies studying efficacy of right atrial ablation and postablation AAD therapy in refractory atrial fibrillation were considered. The primary outcome was reduction of atrial fibrillation burden. The secondary outcome was significant adverse events. We searched Medline, EMBASE, CINAHL, and Cochrane databases. Data collection, analysis, and selection of studies were done independently by two review authors. We included six studies with variable numbers of participants and outcomes. We defined success of hybrid therapy as reduced burden of atrial fibrillation. Total subjects studied was 189, 26% female and 74% male. Average age was 58 years. Left atrial diameter was less than 5 cm and mean ejection fraction was 64%. Mean atrial fibrillation duration was 3.35 years. Most patients had failed at least two AADs. Hybrid therapy was successful in 82% patients. All forms of hybrid therapy consisting of right atrial ablation and AAD therapy seem to be reasonably effective in relief of symptoms from refractory atrial fibrillation with minimal side effects; however, much larger randomized trials need to be performed before a significant superiority of any one may be established.
Authors:
Saneka Chakravarty; Saurav Chatterjee
Related Documents :
15690326 - Percutaneous radiofrequency ablation for hepatocellular carcinoma. an analysis of 1000 ...
1895476 - Successful surgical treatment of atrial fibrillation. review and clinical update.
17495256 - Observations on the safety and effectiveness of dofetilide in patients with paroxysmal ...
15724496 - Oral cibenzoline reduces postoperative atrial fibrillation in coronary artery bypass gr...
2589256 - The prevalence of orthodontic extractions.
23910586 - Risk factors for midterm cardiac function deterioration after valve replacement surger...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of therapeutics     Volume:  19     ISSN:  1536-3686     ISO Abbreviation:  Am J Ther     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-01-09     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9441347     Medline TA:  Am J Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e18-20     Citation Subset:  IM    
Affiliation:
1Department of Internal Medicine, University of Connecticut, Farmington, CT; and 2Department of Internal Medicine, Maimonides Medical Center, Brooklyn, NY.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effect of statin therapy on ventricular tachyarrhythmias: a meta-analysis.
Next Document:  Innate immunity, allergy and atopic dermatitis.